GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » EV-to-EBIT

MDxHealth (MDxHealth) EV-to-EBIT : -2.48 (As of Apr. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is MDxHealth EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MDxHealth's Enterprise Value is $75.42 Mil. MDxHealth's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-30.41 Mil. Therefore, MDxHealth's EV-to-EBIT for today is -2.48.

The historical rank and industry rank for MDxHealth's EV-to-EBIT or its related term are showing as below:

MDXH' s EV-to-EBIT Range Over the Past 10 Years
Min: -26.33   Med: -2.61   Max: 0.2
Current: -2.11

During the past 13 years, the highest EV-to-EBIT of MDxHealth was 0.20. The lowest was -26.33. And the median was -2.61.

MDXH's EV-to-EBIT is ranked worse than
100% of 108 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.19 vs MDXH: -2.11

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MDxHealth's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil. MDxHealth's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-30.41 Mil. MDxHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.


MDxHealth EV-to-EBIT Historical Data

The historical data trend for MDxHealth's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth EV-to-EBIT Chart

MDxHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.54 -3.35 -4.40 -3.06 -

MDxHealth Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.06 0.20 -2.12 -2.25 -

Competitive Comparison of MDxHealth's EV-to-EBIT

For the Diagnostics & Research subindustry, MDxHealth's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MDxHealth's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MDxHealth's EV-to-EBIT falls into.



MDxHealth EV-to-EBIT Calculation

MDxHealth's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=75.420/-30.405
=-2.48

MDxHealth's current Enterprise Value is $75.42 Mil.
MDxHealth's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MDxHealth  (NAS:MDXH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MDxHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-30.405/0
= %

MDxHealth's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil.
MDxHealth's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MDxHealth EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MDxHealth's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MDxHealth (MDxHealth) Business Description

Traded in Other Exchanges
N/A
Address
Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.